medigraphic.com
ISSN 1561-3011 (Digital)

2022, Número 1

<< Anterior Siguiente >>

Rev Cubana Invest Bioméd 2022; 41 (1)


Oxigenoterapia domiciliaria y capacidad aeróbica en pacientes con enfermedad pulmonar intersticial difusa. Estudio transversal

Betancourt PJ, Rodríguez CJ, Rosero-CHE

Idioma: Español
Referencias bibliográficas: 35
Paginas: 1-22
Archivo PDF: 286.04 Kb.


RESUMEN

Introducción: La enfermedad pulmonar intersticial difusa es un grupo de enfermedades que causan un trastorno de la capacidad aeróbica y calidad de vida, además, ocasionan una gran tasa de morbimortalidad para esta población. El uso de oxigenoterapia domiciliaria mayor a 15 horas diarias tiene beneficios en pacientes hipoxémicos crónicos, sin embargo, poco se ha comparado su uso con pacientes que no lo reciben.
Objetivo: Describir las características clínicas, capacidad aeróbica funcional y calidad de vida relacionada con la salud de dos grupos de pacientes con enfermedad pulmonar intersticial difusa, uno con indicación de oxigenoterapia domiciliaria y otro grupo sin indicación.
Métodos: Estudio descriptivo transversal, que incluyó 41 pacientes con enfermedad pulmonar intersticial difusa que firmaron consentimiento informado. En ambos grupos, características demográficas y clínicas, ansiedad/depresión, calidad de vida relacionada con la salud con el cuestionario Saint George y la capacidad aeróbica funcional con la prueba de marcha de seis minutos fueron medidas. Se compararon los grupos con la prueba t de student para muestras independientes.
Resultados: El grupo enfermedad pulmonar intersticial difusa con oxigenoterapia domiciliaria presentó mayor porcentaje de antecedente de tabaquismo (p = 0,041), menor distancia caminada en la prueba de marcha de seis minutos (304,1 ± 108,7 vs. 390,3 ± 95,6 p = 0,01), y menor porcentaje de la distancia predicha (58,37 ± 20,45 vs. 73,34 ± 22,90, p = 0,034) frente al grupo enfermedad pulmonar intersticial difusa sin oxigenoterapia domiciliaria.
Conclusiones: Los pacientes con enfermedad pulmonar intersticial difusa con indicación de oxigenoterapia domiciliaria presentan menor capacidad aeróbica funcional comparada con pacientes sin indicación.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mueller Mang C, Ringl H, Herold C. Interstitial lung diseases. Multislice CT. 2019;261–88. DOI: https://10.1007/174_2017_151

  2. Tonelli R, Cocconcelli E, Lanini B, Romagnoli I, Florini F, Castaniere I, et al. Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: A multicenter prospective study. BMC Pulm Med. 2017;17(1):130. DOI: https://10.1186/s12890-017-0476-5

  3. Rivera-Ortega P, Molina-Molina M. Interstitial lung diseases in developing countries. Ann Glob Heal. 2019;85(1):1–14. DOI: https://10.5334/aogh.2414

  4. Holland AE. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options. Chron Respir Dis. 2010;7(2):101–11. DOI: https://10.1177/1479972309354689

  5. Lindell KO. Nonpharmacological Therapies for Interstitial Lung Disease. Curr Pulmonol Rep. 2018;7(4):126–32. DOI: https://10.1007/s13665-018-0211-6

  6. Carvajalino S, Reigada C, Johnson MJ, Dzingina M, Bajwah S. Symptom prevalence of patients with fibrotic interstitial lung disease: A systematic literature review. BMC Pulm Med. 2018;18(1):78. DOI: https://10.1186/s12890-018-0651-3

  7. Mikolasch TA, Garthwaite HS, Porter JC. Update in diagnosis and management of interstitial lung Disease. Clin Med. 2017;17(2):146–53. DOI: https://10.7861/clinmedicine.17-2-146

  8. Moua T, Westerly BD, Dulohery MM, Daniels CE, Ryu JH, Lim KG. Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: A large cohort analysis. Chest. 2016;149(5):1205–14. DOI: https://10.1016/j.chest.2015.12.026

  9. Betancourt-Peña J, Tonguino-Rosero S, Rosero-Carvajal HE, Hurtado H. Differences of pulmonary rehabilitation in COPD patients, with and without indication for long-term domiciliary oxygen. Fisioterapia. 2018;40(4):169–77. DOI: https://10.1016/j.ft.2018.03.005

  10. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350(10):1005–12. DOI: https://10.1056/NEJMoa021322

  11. Yamamoto-Furusho JK, Sarmiento-Aguilar A, García-Alanis M, Gómez-García LE, Toledo-Mauriño J, Olivares-Guzmán L, et al. Hospital Anxiety and Depression Scale (HADS): Validation in Mexican patients with inflammatory bowel disease. Gastroenterol y Hepatol (English Ed. 2018;41(8):477–82. DOI: https://10.1016/j.gastre.2018.08.009

  12. Betancourt-Peña J, Hurtado-Gutiérrez H. Efectos de un programa de rehabilitación pulmonar en pacientes con enfermedad pulmonar Intersticial difusa. Fisioterapia. 2015;37(6):286–92. DOI: https://10.1016/j.ft.2014.12.001

  13. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European respiratory society/American thoracic society technical standard: Field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46. DOI: https://10.1183/09031936.00150314

  14. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. Ninth edit. Lippincott Williams & Wilkins; 2014. 456 p.

  15. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824. DOI: https://10.1164/rccm.2009-040GL

  16. Torres del Castillo N, Paredes L, Shek N, Hurtado Gutierrez H, Betancourt-Peña J. Benefits of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases. Chest. 2017;152(4):A982. DOI: https://10.1016/j.chest.2017.08.1018

  17. Carey MA, Card JW, Voltz JW, Arbes SJ, Germolec DR, Korach KS, et al. It’s all about sex: gender, lung development and lung disease. Trends Endocrinol Metab. 2007;18(8):308–13. DOI: https://10.1016/j.tem.2007.08.003

  18. Ministerio de salud y Protección Social. SENT 2. Morbi-Mortalidad de las enfermedades respiratorias crónicas, Colombia 2005-2013. Convenio 519 de 2015. Bogotá; 2016 Apr.

  19. Rinaldi S, Mura M, Madill J. Obesity in Interstitial Lung Disease Patients. Can J Diabetes. 2015;39:S59–60. DOI: https://10.1016/j.jcjd.2015.01.224

  20. Ramadurai D, Riordan M, Graney B, Churney T, Olson AL, Swigris JJ. The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung disease. Respir Med. 2018;138:32–7. DOI: https://10.1016/j.rmed.2018.03.025

  21. Brown SAW, Dobelle M, Padilla M, Agovino M, Wisnivesky JP, Hashim D, et al. Idiopathic Pulmonary Fibrosis and Lung Cancer A Systematic Review and Meta-analysis. Ann Am Thorac Soc. 2019;16(8):1041–51. DOI: https://10.1513/AnnalsATS.201807-481OC

  22. Ekström M, Gustafson T, Boman K, Nilsson K, Tornling G, Murgia N, et al. Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: A population-based case-control study. BMJ Open. 2014;4(1):e004018. DOI: https://10.1136/bmjopen-2013-004018

  23. Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, et al. Interpretation of quality of life scores from the St George’s Respiratory Questionnaire. Eur Respir J. 2002;19(3):405–13. DOI: https://10.1183/09031936.02.00213202

  24. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;2014(10). DOI: https://10.1002/14651858.CD006322.pub3

  25. Lancaster LH. Utility of the six-minute walk test in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med. 2018;13(1):1–7. DOI: https://10.1186/s40248-018-0158-z

  26. Khor YH, Renzoni EA, Visca D, McDonald CF, Goh NSL. Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns. ERJ Open Res. 2019;5(3):00118–2019. DOI: https://10.1183/23120541.00118-2019

  27. Crockett A, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev. 2001;(3):CD002883. DOI: https://10.1002/14651858.cd002883

  28. Lim RK, Humphreys C, Morisset J, Holland AE, Johannson KA. Oxygen in patients with fibrotic interstitial lung disease: An international Delphi survey. Eur Respir J. 2019;54(2):1900421. DOI: https://10.1183/13993003.00421-2019

  29. Caminati A, Bianchi A, Cassandro R, Rosa Mirenda M, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med. 2009;103(1):117–23. DOI: https://10.1016/j.rmed.2008.07.022

  30. Lederer DJ, Arcasoy SM, Wilt JS, D’Ovidio F, Sonett JR, Kawut SM. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(6):659–64. DOI: https://10.1164/rccm.200604-520OC

  31. Akhtar AA, Ali MA, Smith RP. Depression in patients with idiopathic pulmonary fibrosis. Chron Respir Dis. 2013;10(3):127–33. DOI: https://10.1177/1479972313493098

  32. Ryerson CJ, Arean PA, Berkeley J, Carrieri Kohlman VL, Pantilat SZ, Landefeld CS, et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology. 2012;17(3):525–32. DOI: https://10.1111/j.1440-1843.2011.02122.x

  33. Khor YH, Goh NSL, Glaspole I, Holland AE, McDonald CF. Exertional desaturation and prescription of ambulatory oxygen therapy in interstitial lung disease. Respir Care. 2019;64(3):299–306. DOI: https://10.4187/respcare.06334

  34. Nathan SD, Du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, et al. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med. 2015;109(7):914–22. DOI: https://10.1016/j.rmed.2015.04.008

  35. Chéhère B, Bougault V, Gicquello A, Wallaert B. Cardiorespiratory Response to Different Exercise Tests in Interstitial Lung Disease. Med Sci Sport Exerc. 2016;48(12):2345–52. DOI: https://10.1249/MSS.0000000000001051




2020     |     www.medigraphic.com